Janux Therapeutics Inc (JANX)
US Market

Janux Therapeutics Inc (JANX) Financial Statements


Janux Therapeutics Inc Financial Overview

Janux Therapeutics Inc's market cap is currently ―. The company's EPS TTM is $-1.224; its P/E ratio is -33.45; Janux Therapeutics Inc is scheduled to report earnings on August 6, 2024, and the estimated EPS forecast is $-0.31. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 2.46M$ 2.52M$ 1.06M-$ 2.85M
Gross Profit$ 2.46M$ 2.52M$ 1.06M--
EBIT$ -16.14M$ -11.57M$ -17.51M$ -20.28M$ -18.27M
EBITDA$ -15.61M-$ -18.88M$ -21.51M$ -19.16M
Net Income Common Stockholders$ -11.76M$ -11.57M$ -17.51M$ -17.46M$ -16.07M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 344.03M$ 349.71M$ 303.29M$ 316.88M$ 327.02M
Total Assets$ 380.41M$ 386.85M$ 341.50M$ 352.96M$ 364.01M
Total Debt$ 24.54M$ 24.89M$ 25.23M$ 25.54M$ 25.30M
Net Debt$ -319.49M$ -324.82M$ -278.06M$ -291.33M$ -301.71M
Total Liabilities$ 36.06M$ 37.90M$ 42.03M$ 41.69M$ 43.27M
Stockholders Equity$ 344.35M$ 348.95M$ 299.51M$ 311.26M$ 320.74M
Cash Flow-
Free Cash Flow$ -10.42M-$ -15.63M$ -14.20M$ -13.97M
Operating Cash Flow$ -9.90M$ -11.71M$ -15.05M$ -13.91M$ -11.91M
Investing Cash Flow$ 11.12M$ -61.45M$ 17.87M$ -8.74M$ -1.60M
Financing Cash Flow$ 831.00K$ 56.61M$ 528.00K$ 1.58M$ 191.00K
Currency in USD

Janux Therapeutics Inc Earnings and Revenue History

Janux Therapeutics Inc Debt to Assets

Janux Therapeutics Inc Cash Flow

Janux Therapeutics Inc Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis